- 19 January 2021Portfolio NewsHillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc.
- 12 January 2021Portfolio NewsBoehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies
- 12 January 2021Portfolio NewsArtios Pharma Appoints Abid Ansari as Chief Financial Officer
- 11 January 2021Portfolio NewsA United Front to Improve Health Outcomes in Northeast Kansas: Healthify's Latest Partnership
- 6 January 2021Portfolio NewsRibometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics
- 4 January 2021Portfolio NewsCareSource and Healthify to Address Social Determinants of Health The two organizations will create a statewide accountable social service network.
- 16 December 2020Portfolio NewsEnara Bio adds further world‐class cell therapy and immuno‐oncology expertise to Senior Management Team and Scientific Advisory Board
- 15 December 2020SV NewsSV Health Investors Promotes Greg Madden to Managing Partner
- 9 December 2020Portfolio NewsEnara Bio relocates to The Oxford Science Park's newest facility to expand R&D capabilities in the search for novel cancer immunotherapies
- 3 December 2020Portfolio NewsMerck KGaA and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
- 1 December 2020Portfolio NewsAdaptHealth Corp. Announces Acquisition of National HME Provider AeroCare Holdings Inc. and Updates Financial Guidance For 2021
- 23 November 2020Portfolio NewsCatamaran Bio Launches with $42 Million Financing to Develop Off-the-Shelf CAR-NK Cell Therapies to Treat Solid Tumors